文献速递腹部介入MR

磁共振引导高强度聚焦超声能否消融靠近粗大门静脉和肝静脉的肝脏病灶?一项猪模型实验研究

Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model.
PubMed 文献 · Eur Radiol · 2019-02-08

在6只雄性陆地猪全麻下用MRgHIFU对邻近直径≥5 mm肝静脉或门静脉的肝组织行消融,共153次消融、81个消融单元、12个消融簇;T1w增强MRI均见无灌注区,组织病理示全部12个消融簇出血坏死、血管壁完整,8 mm消融中肝静脉组热沉效应43%高于门静脉组19%(p=0.04)。作者认为邻近大血管的肝组织消融可行。

要点

  • MRgHIFU可在肝静脉或门静脉旁形成凝固性坏死,组织病理示血管壁完整无破裂。
  • 8 mm消融中热沉效应肝静脉组43%高于门静脉组19%(p=0.04)。
  • 消融簇距血管壁中位最短距离0.4 mm(范围0-2.7 mm),伴水肿和内皮肿胀。

核心结论

  • 邻近粗大肝血管的肝组织可被MRgHIFU消融产生凝固性坏死并保持血管壁完整,提示肝内血管旁肿瘤消融在该实验条件下可行。

研究设计与样本

  • 实验研究,6只雄性陆地猪全麻下行MRgHIFU消融,消融单元直径4或8 mm、每只动物2个消融簇,分别邻近肝静脉(n=6)或门静脉(n=6),血管直径≥5 mm,消融功率200 W、频率1.2 MHz,术后以T1w增强MRI、组织病理和HIFU系统消融数据评估。

关键影像表现/征象

  • T1w增强MRI所有动物均见无灌注区的可见病灶;组织病理全部12个消融簇见出血和坏死,消融簇距血管壁中位最短距离0.4 mm(范围0-2.7 mm),见水肿和内皮肿胀但无血管壁破裂。

诊断标准与关键数值

  • 8 mm消融(n=125)中热沉效应检出率肝静脉组43% vs 门静脉组19%(p=0.04)。

临床应用与阅片要点

  • 作者认为肝内血管旁肿瘤消融使用MRgHIFU是可行的。
  • 原文指出高强度聚焦超声消融是一种可用于治疗肝肿瘤的非侵入性治疗方式。
  • 原文指出邻近大血管的肝肿瘤可能可用该方式治疗。

局限性

  • 本研究为猪模型的实验研究。
  • 原文结论称血管旁肿瘤消融的可行性系由本实验所见提示,而非临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Invasive treatment of tumors adjacent to large hepatic vessels is a continuous clinical challenge. The primary aim of this study was to examine the feasibility of ablating liver tissue adjacent to large hepatic and portal veins with magnetic resonance imaging-guided high-intensity focused ultrasound (MRgHIFU). The secondary aim was to compare sonication data for ablations performed adjacent to hepatic veins (HV) versus portal veins (PV).

MATERIALS AND METHODS: MRgHIFU ablations were performed in six male land swine under general anesthesia. Ablation cells of either 4 or 8 mm diameter were planned in clusters (two/animal) adjacent either to HV (n = 6) or to PV (n = 6), with diameter ≥ 5 mm. Ablations were made using 200 W and 1.2 MHz. Post-procedure evaluation was made on contrast-enhanced MRI (T1w CE-MRI), histopathology, and ablation data from the HIFU system.

RESULTS: A total of 153 ablations in 81 cells and 12 clusters were performed. There were visible lesions with non-perfused volumes in all animals on T1w CE-MRI images. Histopathology showed hemorrhage and necrosis in all 12 clusters, with a median shortest distance to vessel wall of 0.4 mm (range 0-2.7 mm). Edema and endothelial swelling were observed without vessel wall rupture. In 8-mm ablations (n = 125), heat sink was detected more often for HV (43%) than for PV (19%; p = 0.04).

CONCLUSIONS: Ablations yielding coagulative necrosis of liver tissue can be performed adjacent to large hepatic vessels while keeping the vessel walls intact. This indicates that perivascular tumor ablation in the liver is feasible using MRgHIFU.

KEY POINTS: • High-intensity focused ultrasound ablation is a non-invasive treatment modality that can be used for treatment of liver tumors. • This study shows that ablations of liver tissue can be performed adjacent to large hepatic vessels in an experimental setting. • Liver tumors close to large vessels can potentially be treated using this modality.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Carling U, Barkhatov L, Reims HM, et al. Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model. Eur Radiol. 2019. PMID: 30737565. doi:10.1007/s00330-018-5996-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。